Milan, Italy

Michele Marini

This inventor holds 1 USPTO granted patent. Top assignees: Fresenius Medical Care Deutschland Gmbh, Fresenius Medical Care Holdings, Inc.. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Michele Marini. Retrieved from https://idiyas.com/inventor/michele-marini-gzmw02im

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 20.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Michele Marini - Pioneering Inventor from Milan

Introduction: Michele Marini is a distinguished inventor hailing from Milan, Italy, known for his groundbreaking contributions to various fields of technology and innovation.

Latest Patents: Michele Marini holds several recent patents in the areas of renewable energy, sustainable materials, and artificial intelligence, showcasing his commitment to creating solutions for the future.

Career Highlights: With a career spanning over two decades, Michele Marini has worked with leading research institutions and universities to develop cutting-edge technologies that have revolutionized industries worldwide.

Collaborations: Throughout his career, Michele Marini has collaborated with top companies, innovative startups, and visionary entrepreneurs to bring his inventions to market, solidifying his reputation as a sought-after expert in the field of innovation.

Conclusion: Michele Marini's passion for innovation, coupled with his relentless drive to push the boundaries of what is possible, has cemented his legacy as a trailblazing inventor whose work continues to inspire generations to come.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…